Antipsychotics
5
1
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
8 treatments under study, led by Insulin Lispro 100 Untml
Research Leaders
9 sponsors active, led by Department of Health, Executive Yuan, R.O.C. (Taiwan)
Related Conditions
Often studied with 11 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Effects of Antipsychotics on Brain Insulin Action in Females
Maternal And Infant Antipsychotic Study
MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
Change in Brain Metabolism and Cognitive Function by Aripiprazole
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
Research Network
Common Treatments
- Insulin Lispro 100 Untml1
- Nonantipsychotic Medication1
- Olanzapine1
- Antipsychotics1
- No Medication1
Active Sponsors
- Department of Health, Executive Yuan, R.O.C. (Taiwan)1
- Erasmus Medical Center1
- Korea Otsuka Pharmaceutical Co., Ltd.1
- Icahn School of Medicine at Mount Sinai1
- Taipei Medical University Hospital1
Top Investigators
Centre for Addiction and Mental Health
Seoul National University Hospital
Seoul National University Hospital
Icahn School of Medicine at Mount Sinai
Related Conditions
- Schizophrenia2
- Aripiprazole1
- Menstrual Cycle1
- Cognition1
- Insulin Resistance1